Yerly S - Search Results

1

Successful Prevention of Transmission of Integrase Resistance in the Swiss HIV Cohort Study.

Scherrer AU, Yang WL, Kouyos RD, Böni J, Yerly S, Klimkait T, Aubert V, Cavassini M, Battegay M, Hauser C, Calmy A, Schmid P, Bernasconi E, Günthard HF; Swiss HIV Cohort Study. Scherrer AU, et al. Among authors: yerly s. J Infect Dis. 2016 Aug 1;214(3):399-402. doi: 10.1093/infdis/jiw165. Epub 2016 Apr 29. J Infect Dis. 2016. PMID: 27130429 Free article.

2

Quantitation of human immunodeficiency virus provirus and circulating virus: relationship with immunologic parameters.

Yerly S, Chamot E, Hirschel B, Perrin LH. Yerly S, et al. J Infect Dis. 1992 Aug;166(2):269-76. doi: 10.1093/infdis/166.2.269. J Infect Dis. 1992. PMID: 1353103

3

Absence of chronic human immunodeficiency virus infection without seroconversion in intravenous drug users: a prospective and retrospective study.

Yerly S, Chamot E, Déglon JJ, Hirschel B, Perrin LH. Yerly S, et al. J Infect Dis. 1991 Nov;164(5):965-8. doi: 10.1093/infdis/164.5.965. J Infect Dis. 1991. PMID: 1940476

4

Foscarnet decreases human immunodeficiency virus RNA.

Kaiser L, Perrin L, Hirschel B, Furrer H, Von Overbeck J, Olmari M, Yerly S. Kaiser L, et al. Among authors: yerly s. J Infect Dis. 1995 Jul;172(1):225-7. doi: 10.1093/infdis/172.1.225. J Infect Dis. 1995. PMID: 7797916 Clinical Trial.

5

Prognostic value of viremia in patients with long-standing human immunodeficiency virus infection. Swiss HIV Cohort Study Group.

Galetto-Lacour A, Yerly S, Perneger TV, Baumberger C, Hirschel B, Perrin L. Galetto-Lacour A, et al. Among authors: yerly s. J Infect Dis. 1996 Jun;173(6):1388-93. doi: 10.1093/infdis/173.6.1388. J Infect Dis. 1996. PMID: 8648210

6

Toxicity, efficacy, plasma drug concentrations and protease mutations in patients with advanced HIV infection treated with ritonavir plus saquinavir. Swiss HIV Cohort Study.

Lorenzi P, Yerly S, Abderrakim K, Fathi M, Rutschmann OT, von Overbeck J, Leduc D, Perrin L, Hirschel B. Lorenzi P, et al. Among authors: yerly s. AIDS. 1997 Oct;11(12):F95-9. doi: 10.1097/00002030-199712000-00002. AIDS. 1997. PMID: 9342060 Clinical Trial.

7

A critical assessment of the prognostic value of HIV-1 RNA levels and CD4+ cell counts in HIV-infected patients. The Swiss HIV Cohort Study.

Yerly S, Perneger TV, Hirschel B, Dubuis O, Matter L, Malinverni R, Furrer H, Perrin L. Yerly S, et al. Arch Intern Med. 1998 Feb 9;158(3):247-52. doi: 10.1001/archinte.158.3.247. Arch Intern Med. 1998. PMID: 9472204

8

A placebo-controlled trial of didanosine plus stavudine, with and without hydroxyurea, for HIV infection. The Swiss HIV Cohort Study.

Rutschmann OT, Opravil M, Iten A, Malinverni R, Vernazza PL, Bucher HC, Bernasconi E, Sudre P, Leduc D, Yerly S, Perrin LH, Hirschel B. Rutschmann OT, et al. Among authors: yerly s. AIDS. 1998 May 28;12(8):F71-7. doi: 10.1097/00002030-199808000-00003. AIDS. 1998. PMID: 9631134 Clinical Trial.

9

Codon 215 mutations in human immunodeficiency virus-infected pregnant women. Swiss Collaborative 'HIV and Pregnancy' Study.

Kully C, Yerly S, Erb P, Kind C, Krautheim A, Perrin L, Rudin C. Kully C, et al. Among authors: yerly s. J Infect Dis. 1999 Mar;179(3):705-8. doi: 10.1086/314615. J Infect Dis. 1999. PMID: 9952382

10

Impact of drug resistance mutations on virologic response to salvage therapy. Swiss HIV Cohort Study.

Lorenzi P, Opravil M, Hirschel B, Chave JP, Furrer HJ, Sax H, Perneger TV, Perrin L, Kaiser L, Yerly S. Lorenzi P, et al. Among authors: yerly s. AIDS. 1999 Feb 4;13(2):F17-21. doi: 10.1097/00002030-199902040-00001. AIDS. 1999. PMID: 10202819

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

525 results

Search Page

Filters